We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WILC icon
3476
G. Willi-Food International
WILC
$403M
$2K ﹤0.01%
300
-345
-53% -$1.94K
WVVI icon
3477
Willamette Valley Vineyards
WVVI
$11.9M
$2K ﹤0.01%
303
-413
-58% -$3.35K
YPF icon
3478
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
$2K ﹤0.01%
100
-970
-91% -$16.6K
YRD
3479
Yiren Digital
YRD
$110M
$2K ﹤0.01%
+103
New +$2.8K
ATYR
3480
aTyr Pharma
ATYR
$50.1M
$2K ﹤0.01%
80
-28
-26% -$1.15K
ENFY
3481
DELISTED
Enlightify Inc
ENFY
$2K ﹤0.01%
+132
New +$2.08K
NAGE
3482
Niagen Bioscience
NAGE
$247M
$2K ﹤0.01%
+572
New +$1.55K
TBNK
3483
DELISTED
Territorial Bancorp Inc.
TBNK
$2K ﹤0.01%
53
-2,635
-98% -$80.5K
USAP
3484
DELISTED
Universal Stainless & Alloy
USAP
$2K ﹤0.01%
163
+99
+155% +$1.17K
DXYN
3485
DELISTED
Dixie Group Inc
DXYN
$2K ﹤0.01%
667
-1,934
-74% -$7.53K
KA
3486
DELISTED
Kineta, Inc. Common Stock
KA
$2K ﹤0.01%
1
-28
-97% -$45.7K
EGIO
3487
DELISTED
Edgio, Inc. Common Stock
EGIO
$2K ﹤0.01%
+22
New +$1.87K
VBIV
3488
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$2K ﹤0.01%
20
-17
-46% -$1.62K
TARO
3489
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$2K ﹤0.01%
20
-142
-88% -$14.9K
AAU
3490
DELISTED
Almaden Minerals Ltd
AAU
$2K ﹤0.01%
1,700
-100
-6% -$115
GPP
3491
DELISTED
Green Plains Partners LP
GPP
$2K ﹤0.01%
+122
New +$2.33K
SVVC
3492
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$2K ﹤0.01%
+231
New +$1.84K
APTO
3493
DELISTED
Aptose Biosciences, Inc.
APTO
$2K ﹤0.01%
+2
New +$1.25K
BSMX
3494
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$2K ﹤0.01%
334
+58
+21% +$466
SIOX
3495
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2K ﹤0.01%
19
-559
-97% -$58.9K
HIL
3496
DELISTED
Hill International, Inc. Common Stock
HIL
$2K ﹤0.01%
+500
New +$1.99K
TMX
3497
DELISTED
Terminix Global Holdings, Inc.
TMX
$2K ﹤0.01%
+60
New +$1.47K
ABTX
3498
DELISTED
Allegiance Bancshares
ABTX
$2K ﹤0.01%
+53
New +$1.6K
VOLT
3499
DELISTED
Volt Information Sciences, Inc.
VOLT
$2K ﹤0.01%
356
-1,654
-82% -$10.4K
MFL
3500
DELISTED
BLACKROCK MUNIHOLDINGS INVESTMENT QUALITY FUND
MFL
$2K ﹤0.01%
+170
New +$2.47K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.